Advertisement
U.S. markets closed

  • S&P 500

    4,550.58
    -4.31 (-0.09%)
     

  • Dow 30

    35,430.42
    +13.44 (+0.04%)
     

  • Nasdaq

    14,258.49
    -23.27 (-0.16%)
     

  • Russell 2000

    1,803.81
    +11.00 (+0.61%)
     

  • Crude Oil

    77.67
    -0.19 (-0.24%)
     

  • Gold

    2,066.10
    -1.00 (-0.05%)
     

  • Silver

    25.41
    -0.04 (-0.15%)
     

  • EUR/USD

    1.0981
    +0.0006 (+0.05%)
     

  • 10-Yr Bond

    4.2710
    -0.0650 (-1.50%)
     

  • GBP/USD

    1.2696
    +0.0002 (+0.02%)
     

  • USD/JPY

    147.0200
    -0.0340 (-0.02%)
     

  • Bitcoin USD

    37,815.82
    -68.92 (-0.18%)
     

  • CMC Crypto 200

    780.70
    -4.80 (-0.61%)
     

  • FTSE 100

    7,423.46
    -31.78 (-0.43%)
     

  • Nikkei 225

    33,227.61
    -93.61 (-0.28%)
     

Novavax partners with contract drugmaker for COVID-19 vaccine manufacturing

Reuters

June 3 (Reuters) - Novavax Inc on Wednesday entered into a deal with contract drugmaker AGC Biologics to manufacture its experimental COVID-19 vaccine.

An add-on component of Novavax's vaccine that could help enhance the immune response against the coronavirus would be manufactured by privately held AGC Biologics, the contract drugmaker said. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Saumyadeb Chakrabarty)

Advertisement